Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Anne C. Whitaker, to the company’s Board of Directors (the Board). Ms. Whitaker is a seasoned ...

Alkermes is upgraded to Buy on strong revenue growth, Lumryz momentum, and orexin pipeline upside in sleep/CNS. Click to get ...

— Stage One Submission Period Runs From Sept. 11, 2026 Through Oct. 16, 2026 — ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Alkermes is transitioning into an integrated neuroscience and sleep medicine company, highlighted by the Avadel acquisition and LUMRYZ integration. Q1 2026 results show proprietary product sales ...

Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. For more information, please visit Alkermes’ ...

DUBLIN, June 8, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) (the Company) today announced that it has filed an investor presentation with the U.S. Securities and Exchange Commission (SEC) in ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Alkermes has a portfolio of commercialized neuroscience products and a pipeline that spans both neuroscience and cancer. The drugmaker is now exploring the possibility of splitting off its cancer ...

March 5 (Reuters) - Biotechnology company Alkermes Inc. promoted Chief Operating Officer David Broecker to the post of chief executive officer. Broecker succeeds CEO Richard Pops, who will become ...

Alkermes Inc. was hit with an antitrust class action on Oct. 2 in Massachusetts District Court over a monopolization scheme to block generic competition for Vivitrol, an anti-opioid injection. The ...

BOSTON (Reuters) - Alkermes Inc said on Wednesday it is cutting 150 jobs, closing a manufacturing facility and taking restructuring charges of up to $25 million following the decision by partner Eli ...